alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
UNITED STATES COURT OF APPEALS
FOR THE TENTH CIRCUIT

________________ _________________ UNITED STATES OF AMERICA, Plaintiff - Appellee,

v. BENNIE AARON JONES, Defendant - Appellant. No. 16-1223 (D.C. No. 1:15-CR-00304-WYD-1) (D. Colo.)

________________ _________________ ORDER AND JUDGMENT 

________________ _________________ Before MATHESON , BACHARACH , and PHILLIPS , Circuit Judges.

________________ _________________ This matter is before us on Appellee’s Unopposed Motion for Summary Affirmance . The United States moves for summary affirmance of the district court’s sentencing determination in this case in light of the Supreme Court’s decision in Beckles
v. United States , __S. Ct.__, 2017 WL 8 55781 (March 6, 2017). Appellant Bennie Aaron Jones does not oppose the motion. Upon consideration, the motion is granted. The judgment of the district court is
affirmed.

 This order and judgment is not binding precedent, exce pt under the doctrines of law of the case, res judicata, and collateral es toppel. It may be cited, however, for its persuasive value consistent with Fed. R. App. P. 32.1 and 10th Cir. R. 32.1. FILED United States Court of Appeals Tenth Circuit 

### March 8, 2017
Elisabeth A. Shumaker Clerk of Court2 The mandate shall issue forthwith.

Entered for the Court Per Curiam
[Federal Register Volume 80, Number 16 (Monday, January 26, 2015)]
[Notices]
[Page 3985]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-01294]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Manufacturer of Controlled Substances Registration: Wildlife 
Laboratories, Inc.

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Wildlife Laboratories, Inc. applied to be registered as a 
manufacturer of a basic class of controlled substance. The DEA grants 
Wildlife Laboratories, Inc. registration as a manufacturer of this 
controlled substance.

SUPPLEMENTARY INFORMATION: By notice dated May 28, 2014, and published 
in the Federal Register on June 3, 2014, 79 FR 31985, Wildlife 
Laboratories, Inc., 1230 W. Ash Street, Suite D, Windsor, Colorado 
80550, applied to be registered as a manufacturer of a certain basic 
class of controlled substance. No comments or objections were submitted 
to this notice.
    The Drug Enforcement Administration (DEA) has considered the 
factors in 21 U.S.C. 823(a) and determined that the registration of 
Wildlife Laboratories, Inc. to manufacture the basic class of 
controlled substance is consistent with the public interest and with 
United States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. The DEA investigated the company's 
maintenance of effective controls against diversion by inspecting and 
testing the company's physical security systems, verifying the 
company's compliance with state and local laws, and reviewing the 
company's background and history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above-named company is granted registration as a bulk 
manufacturer of Carfentanil (9743), a basic class of controlled 
substance listed in schedule II.
    The company plans to manufacture the above listed controlled 
substance for sale to veterinary pharmacies, zoos, and other animal and 
wildlife applications.

    Dated: January 9, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-01294 Filed 1-23-15; 8:45 am]
BILLING CODE P
<TABLE> <S> <C>


<ARTICLE>                     5
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                              DEC-31-1999
<PERIOD-START>                                 JAN-02-1999
<PERIOD-END>                                   APR-02-1999
<CASH>                                              63,000
<SECURITIES>                                             0
<RECEIVABLES>                                    4,520,000
<ALLOWANCES>                                       178,000
<INVENTORY>                                     16,652,000
<CURRENT-ASSETS>                                21,111,000
<PP&E>                                           4,746,000
<DEPRECIATION>                                   1,133,000
<TOTAL-ASSETS>                                  29,675,000
<CURRENT-LIABILITIES>                            4,525,000
<BONDS>                                         19,804,000
<PREFERRED-MANDATORY>                                    0
<PREFERRED>                                              0
<COMMON>                                           372,000
<OTHER-SE>                                       4,974,000
<TOTAL-LIABILITY-AND-EQUITY>                    29,675,000
<SALES>                                          5,291,000
<TOTAL-REVENUES>                                 5,291,000
<CGS>                                            3,633,000
<TOTAL-COSTS>                                    5,341,000
<OTHER-EXPENSES>                                   222,000
<LOSS-PROVISION>                                         0
<INTEREST-EXPENSE>                                 457,000
<INCOME-PRETAX>                                   (729,000)
<INCOME-TAX>                                         1,000
<INCOME-CONTINUING>                               (730,000)
<DISCONTINUED>                                           0
<EXTRAORDINARY>                                          0
<CHANGES>                                                0
<NET-INCOME>                                      (730,000)
<EPS-PRIMARY>                                        (0.29)
<EPS-DILUTED>                                        (0.29)
        

</TABLE>
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF AMC, INC. FOR THE NINE MONTHS ENDED MAY 31, 1998 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          AUG-31-1998
<PERIOD-END>                               MAY-31-1998
<CASH>                                             556
<SECURITIES>                                         0
<RECEIVABLES>                                    2,769
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                14,108
<PP&E>                                         325,940
<DEPRECIATION>                                 132,210
<TOTAL-ASSETS>                                 227,602
<CURRENT-LIABILITIES>                           28,112
<BONDS>                                        280,942
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        62,173
<OTHER-SE>                                    (152,061)
<TOTAL-LIABILITY-AND-EQUITY>                   227,602
<SALES>                                              0
<TOTAL-REVENUES>                                53,183
<CGS>                                                0
<TOTAL-COSTS>                                   37,554
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                   101
<INTEREST-EXPENSE>                               6,270
<INCOME-PRETAX>                                 15,008
<INCOME-TAX>                                     5,587
<INCOME-CONTINUING>                              9,421
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     9,421
<EPS-PRIMARY>                                      .15
<EPS-DILUTED>                                      .15
        

</TABLE>
HomeNRC LibraryDocument CollectionsNUREG-Series PublicationsConference Proceedings Prepared by NRC Staff or Contractors

# Proceedings of the ACNW Working Group on the Performance Confirmation Plans for the Proposed Yucca Mountain High-Level Waste Repository (NUREG/CP-0190)

On this page:
        - Publication Information
        - Abstract

Download complete document
        - NUREG/BR-0190 (PDF - 8.46 MB)

## Publication Information

**Manuscript Completed:** December 2004**Date Published:** December 2004

**Edited by:** N.M. Coleman, Senior Staff Engineer

U.S. Nuclear Regulatory Commission Washington, DC 20555-0001

Availability Notice

## Abstract

This report contains the information presented at the meeting of the Working Group on Performance Confirmation Plans for the Proposed Yucca Mountain High-Level Waste Repository. This working group session was convened by the Advisory Committee on Nuclear Waste and held at the Nuclear Regulatory Commission headquarters in Rockville, Maryland, on July 29-30, 2003. This report summarizes the presentations given to the Committee, along with the presentation materials and selected discussions among the participants. The working group included a panel of six experts who observed and commented on the proceedings.

The purposes of the working group were (1) to increase ACNW's technical knowledge of plans to develop and conduct performance confirmation (PC) work for the proposed Yucca Mountain repository, (2) to understand NRC staff expectations for performance confirmation, (3) to review examples of performance confirmation work being planned, (4) to identify aspects of performance confirmation that may warrant further study, and (5) to complement the previous working group session on performance assessment.

Page Last Reviewed/Updated Wednesday, March 24, 2021
HomeNRC LibraryDocument CollectionsNUREG-Series PublicationsBrochures Prepared by NRC Staff

# A Journey to Your Future:  Make Discovering Your Career an Adventure (NUREG/BR-0474)

Page Last Reviewed/Updated Wednesday, March 24, 2021
115TH CONGRESS 

1ST SESSION H. R. 1733 

AN ACT 

To direct the Secretary of Energy to review and update 

a report on the energy and environmental benefits of 

the re-refining of used lubricating oil. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 
2 

•HR 1733 EH

1 SECTION 1. ENERGY SAVINGS FROM LUBRICATING OIL. 

2 Not later than 1 year after the date of enactment 

3 of this Act, the Secretary of Energy, in cooperation with 

4 the Administrator of the Environmental Protection Agen5 cy and the Director of the Office of Management and 

6 Budget, shall— 

7 (1) review and update the report prepared pur8 suant to section 1838 of the Energy Policy Act of 

9 2005; 

10 (2) after consultation with relevant Federal, 

11 State, and local agencies and affected industry and 

12 stakeholder groups, update data that was used in 

13 preparing that report; and 

14 (3) prepare and submit to Congress a coordi15 nated Federal strategy to increase the beneficial 

16 reuse of used lubricating oil, that— 

17 (A) is consistent with national policy as es18 tablished pursuant to section 2 of the Used Oil 

19 Recycling Act of 1980 (Public Law 96–463); 

20 and 

21 (B) addresses measures needed to— 

22 (i) increase the responsible collection 

23 of used oil; 

24 (ii) disseminate public information 

25 concerning sustainable reuse options for 

26 used oil; and 
3 

•HR 1733 EH

1 (iii) promote sustainable reuse of used 

2 oil by Federal agencies, recipients of Fed3 eral grant funds, entities contracting with 

4 the Federal Government, and the general 

5 public. 

Passed the House of Representatives December 12, 

2017. 

Attest: 

Clerk. 
115TH CONGRESS 

1ST SESSION H. R. 1733 

AN ACT 

To direct the Secretary of Energy to review and upbenefits of the re-refining of used lubricating oil. date a report on the energy and environmental
No. 82-5836.

#### Ballentine *v.*Harris, Superintendent, Green Haven Correctional Facility.

C. A. 2d Cir. Certiorari denied.
HomeNRC LibraryDocument CollectionsNUREG-Series PublicationsPublications Prepared by NRC Contractors

# Fire Protection Research Program for the U. S. Nuclear Regulatory Commission 1975-1981 (NUREG/CR-2607)

On this page:
        - Publication Information
        - Abstract

Download complete document
        - NUREG/CR-2607 (PDF - 6.40 MB)

## Publication Information

**Date Published:** April 1983

**Prepared by:** Donald A. Dube Systems Safety Technology Division

Sandia National Laboratories Albuquerque, New Mexico 87185 operated by Sandia Corporation for the U. S. Department of Energy

NRC FIN A-1010

**Prepared for:** Division of Engineering Technology Office of Nuclear Regulatory Research U. S. Nuclear Regulatory Commission Washington, DC 20555 Under Memorandum of Understanding DOE 40-550-75

Availability Notice

## Abstract

Since early 1975, Sandia National Laboratories has been conducting fire protection research for the U. S. Nuclear Regulatory Commission. Testing has been done on grouped electrical cable fires including electrical initiation, fire propagation, the effects of fire retardant coatings and barriers, suppression, and characterization of the damageability of electrical cables. In addition, several studies of a more generic nature such as fire detection, ventilation, and fire-hazards analysis methodologies were performed.

This report condenses all of the test results, reports, papers, and research findings of the past seven years. Research conducted by contractors to Sandia National Laboratories is also summarized.

Page Last Reviewed/Updated Wednesday, March 24, 2021
EXHIBIT 32.1

Certification of Principal Executive Officer

Pursuant to 18 U.S.C. 1350

(Section 906 of the Sarbanes-Oxley Act of 2002)

I, David A. Steinberg, Chairman and Chief Executive Officer (principal executive officer) of InPhonic, Inc. (the Registrant), certify that to the best of my knowledge, based upon a review of the Annual
Report on Form 10-K for the period ended December 31, 2006 of the Registrant (the Report):

(1) The Report
fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended; and

(2) The
information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.



/s/ DAVID A. STEINBERGName:

David A. SteinbergDate:

May 31, 2007
HomeNRC LibraryDocument CollectionsNUREG-Series PublicationsPublications Prepared by NRC Contractors

# Evaluation Of Risk Associated With Intergranular Stress Corrosion Cracking In Boiling Water Reactor Internals (NUREG/CR-6677) On this page:

On this page:
        - Publication Information
        - Abstract

Download complete document
        - NUREG/CR-6677	           - Cover – Section 12 (PDF - 11.66 MB)
          - Appendix A – Appendix E (PDF - 7.15 MB) 

## Publication Information

**Manuscript Completed:** June 2000**Date Published:** July 2000

**Prepared by:**A-G. Ware, D.K. Morton, M.E. Nitzel, S.A. Eide

Idaho National Engineering and Environmental LaboratoryBechtel BWXT Idaho, LLCIdaho Falls, ID 83415-3129

T.Y. Chang, NRC Project Manager

**Prepared for:**Division of Engineering TechnologyOffice of Nuclear Regulatory ResearchU.S. Nuclear Regulatory CommissionWashington, DC 20555-0001

NRC Job Code W6677

Availability Notice

## Abstract

Intergranular stress corrosion cracking (IGSCC) has been detected in a number of Boiling Water Reactor (BWR) vessel internals. The number of different types of components that have experienced cracking has increased over the years. Based on evaluations submitted by General Electric, BWR owners, and the BWRVIP group, the Office of Nuclear Reactor Regulation of the Nuclear Regulatory Commission has determined that the short-term risk significance of cracking of BWR vessel internals is acceptable. The purpose of this report is to begin an evaluation of the long-term risk associated with IGSCC of BWR vessel internals. The differences in BWR types were studied, the history of IGSCC cracking in reactor internals was catalogued, and tables of accident scenarios involving cracked internals were developed. Screening methods were developed to reduce the number of accident scenarios that represent more significant risk to a more manageable number, and a final list of potential concerns was developed which ranked the scenarios as having a high, medium, or low impact on increasing the core damage frequency based on a qualitative risk assessment. In order to narrow the scope of the problem, the investigation was limited to a single BWR type (high-power BWR/4). Using several screening methods, the scenarios to investigate were reduced by about 2/3. To further concentrate the investigation and develop a methodology to be used, scenarios resulting from the failure of a single component (jet pump) were evaluated. The evaluation was then extended to the remaining reactor internals components. It was concluded that with the current BWRVIP inspection, monitoring, and repair proposals, there is expected to be no significant increase in CDF (< 5 x 10-6 events/yr) caused by failures of BWR internals. That is, IGSCC problems can be identified and evaluated or corrected, to preclude a significant increase in the CDF.

Page Last Reviewed/Updated Wednesday, March 24, 2021
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 1996 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE IN SUCH STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               SEP-30-1996
<CASH>                                          32,731
<SECURITIES>                                    44,223
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                77,980
<PP&E>                                           9,603
<DEPRECIATION>                                 (1,780)
<TOTAL-ASSETS>                                  86,602
<CURRENT-LIABILITIES>                           18,340
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             1
<OTHER-SE>                                      66,685
<TOTAL-LIABILITY-AND-EQUITY>                    86,602
<SALES>                                              0
<TOTAL-REVENUES>                                 9,506
<CGS>                                                0
<TOTAL-COSTS>                                    8,638
<OTHER-EXPENSES>                                 9,898
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 192
<INCOME-PRETAX>                                (6,302)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (6,302)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (6,302)
<EPS-PRIMARY>                                    (.59)
<EPS-DILUTED>                                        0
        

</TABLE>
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
This schedule contains summary financial information extracted from the
Pharmaceutical Product Development Inc. Consolidated Balance Sheet and Statement
of Operations included within this Form 10-Q and is qualified in its entirety by
reference to such financial statements.
</LEGEND>
<MULTIPLIER>                                   1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                              DEC-31-2000
<PERIOD-START>                                 JAN-01-2000
<PERIOD-END>                                   MAR-31-2000
<CASH>                                         73,687
<SECURITIES>                                   0
<RECEIVABLES>                                  104,508
<ALLOWANCES>                                   998
<INVENTORY>                                    0
<CURRENT-ASSETS>                               198,434
<PP&E>                                         114,173
<DEPRECIATION>                                 60,226
<TOTAL-ASSETS>                                 291,255
<CURRENT-LIABILITIES>                          86,481
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       2,480
<OTHER-SE>                                     199,446
<TOTAL-LIABILITY-AND-EQUITY>                   291,255
<SALES>                                        0
<TOTAL-REVENUES>                               81,761
<CGS>                                          0
<TOTAL-COSTS>                                  42,071
<OTHER-EXPENSES>                               30,398
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             45
<INCOME-PRETAX>                                10,687
<INCOME-TAX>                                   4,047
<INCOME-CONTINUING>                            6,640
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   6,640
<EPS-BASIC>                                    0.27
<EPS-DILUTED>                                  0.27


</TABLE>
#### D. PENDER *v.*GRIFFIN, BRO. & CO.

(See Syllabus in the preceding case.)

This was an appeal by the plaintiff from an order of the Court below, made in the -proceeding case, which order and the fact's relating thereto are fully stated therein.
HomeNRC LibraryDocument CollectionsNews Releases1997

# Note to Editors: Note Location Change

----

----

I-97-139

October 21, 1997

NOTE TO EDITORS: **NOTE LOCATION CHANGE**

The Nuclear Regulatory Commission staff has changed the location of the upcoming meeting with Northeast Utilities to discuss the radiological controls program at the Haddam Neck nuclear power plant in Haddam, Conn. The meeting now will take place on Friday, October 31, at 10 a.m. in the INFORMATION AND SCIENCE CENTER AT THE HADDDAM NECK SITE IN HADDAM, CONN. It will be open to the public for observation.

The meeting is being moved because of public interest.

Page Last Reviewed/Updated Thursday, March 25, 2021
HomeNRC LibraryDocument CollectionsNews Releases1998

# Note to Editors: ACRS Has Scheduled a Meeting on February 3-4

----

----

No. 98-07

January 13, 1998

**NOTE TO EDITORS:**

A subcommittee of the Nuclear Regulatory Commission's Advisory Committee on Reactor Safeguards (ACRS) has scheduled a meeting February 3-4 in Rockville, Maryland.

The meeting, which will be open to public observation, will begin at 1:00 p.m. in Room T-2B3, of the NRC's One White Flint North Building at 11545 Rockville Pike on Tuesday, February 3, and at 8:30 a.m. Wednesday, February 4. The Subcommittee on Advanced Reactor Designs will hear presentations by and hold discussions with representatives of the NRC staff and Westinghouse Electric Corp. on the A600 test and analysis program. Some portions of the meeting dealing with proprietary information may be closed.

Other aspects of the meeting, including an opportunity for public comment, will be described in a Notice of Meeting published in a forthcoming edition of the Federal Register.

Page Last Reviewed/Updated Wednesday, March 24, 2021